Apathy Evaluation as New outcome After Stroke (AENEAS)

Apathy Evaluation as New outcome After Stroke (AENEAS) - Apathy After Stroke

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35801

Enrollment

500

Registered

2011-07-21

Start date

2011-09-28

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

apathy behavioral disorder

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Stroke for which hospitalization was indicated approximately three months ago. Participation in one of two randomized controlled trials in acute stroke (ARTIS-trial, PASS-trial). National Institutes of Health Stroke Scale (NIHSS) 2-20

Exclusion criteria

Exclusion criteria: aphasia; major depression or dementia prior to stroke

Design outcomes

Primary

Measure	Time frame
Primary outcome is the effect of the interventions in the ARTIS and PASS trials on apathy 3 and 9 months after stroke.	—

Secondary

Measure	Time frame
Secondary outcomes are the effect of the interventions in ARTIS and PASS on depression and cognitive function 3 and 9 months after stroke. The effect of apathy, depression and cognitive impairment on functional recovery will be evaluated.	—

Countries

Netherlands

Outcome results